Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06625502 · ClinicalTrials.gov registry record · NA

Unmute's CARE Framework: A Novel Approach to Strengthen the Therapeutic Alliance and Reduce Treatment Disparities

A NA study of Anxiety Symptoms and Depression Scale Score, sponsored by New York University.

Active
Registry status
NA
Development phase
40
Enrollment target
2
Study locations

NCT06625502 is a NA study of Anxiety Symptoms and Depression Scale Score that is active but no longer recruiting, run by New York University. The registered enrollment target is 40 participants, below the 178-participant average among 5 other Anxiety Symptoms trials with a reported enrollment target (78% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06625502, a NA study of Anxiety Symptoms and Depression Scale Score, is active but no longer recruiting, sponsored by New York University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
2
Study locations

Study Summary

Aim 1: Expand and adapt the CARE framework to train providers to cultivate a strong early alliance with patients who do not share their background (e.g., mismatched dyads). Aim 2: Establish the feasibility, acceptability, and preliminary effectiveness of the adapted CARE framework in mismatched dyads involving 8 providers and 40 patients receiving 15 sessions of teletherapy. The goal of this clinical trial is to learn if a new CARE intervention works to improve the cultural fit of psychotherapy for diverse populations, even when the therapist and patient do not share the same cultural background. We will refine and test the intervention with a sample of therapists working with Asian American participants receiving short-term individual psychotherapy delivered online. The main questions the study aims to answer are: * Does the CARE framework, adapted for and delivered by therapists specifically trained to work with patients who do not share their background (e.g., mismatched dyads), improve treatment engagement and retention? * Is the CARE framework associated with a) the development of a positive therapeutic relationship between mismatched patient-therapist dyads and b) significant improvements in participants' presenting problems? Participants will: * Receive up to 15 weekly sessions of individual psychotherapy * Complete different online surveys after every session and on a monthly basis

Interventions

  • BEHAVIORAL Culturally-Affirming Racial Equity Framework

Study Locations (2)

Massachusetts

  • Unmute Enterprise Inc. [A telehealth company] - Chelsea

New York

  • Virtual/Telehealth - New York

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-09-15
Est. Completion 2026-06-01
Phase NA

Sponsor

New York University

83 total trials

What the Registry Record Tells You About NCT06625502

The ClinicalTrials.gov registry entry for NCT06625502 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 178-participant average among 5 other Anxiety Symptoms trials with a reported enrollment target (78% lower). The listed sponsor is New York University, which has 83 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Anxiety Symptoms appearing as the primary indexed condition, and to 1 intervention - of which Culturally-Affirming Racial Equity Framework is the first listed.

NCT06625502 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, New York.

Frequently Asked Questions

What is clinical trial NCT06625502 about?

NCT06625502 is a clinical study titled "Unmute's CARE Framework: A Novel Approach to Strengthen the Therapeutic Alliance and Reduce Treatment Disparities". Aim 1: Expand and adapt the CARE framework to train providers to cultivate a strong early alliance with patients who do not share their background (e.g., mismatched dyads). Aim 2: Establish the feasibility, acceptability, and preliminary effectiveness of the adapted CARE framework in mismatched dyad...

What is the current status of trial NCT06625502?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-09-15. Estimated completion is 2026-06-01.

What conditions does trial NCT06625502 study?

This clinical trial studies the following conditions: Anxiety Symptoms, Depression Scale Score, Functioning, Psychosocial, Working Alliance.

What interventions are being tested in trial NCT06625502?

The interventions under investigation include: Culturally-Affirming Racial Equity Framework (BEHAVIORAL).

Who is sponsoring clinical trial NCT06625502?

This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06625502 being conducted?

This trial has 2 study locations across Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety Symptoms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.